1. Home
  2. COLL vs SPH Comparison

COLL vs SPH Comparison

Compare COLL & SPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$45.76

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Suburban Propane Partners L.P.

SPH

Suburban Propane Partners L.P.

HOLD

Current Price

$20.35

Market Cap

1.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLL
SPH
Founded
2002
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
COLL
SPH
Price
$45.76
$20.35
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$51.17
N/A
AVG Volume (30 Days)
406.2K
163.8K
Earning Date
02-26-2026
02-05-2026
Dividend Yield
N/A
6.42%
EPS Growth
N/A
89.48
EPS
1.63
2.01
Revenue
$757,067,000.00
$1,429,575,000.00
Revenue This Year
$26.17
$2.06
Revenue Next Year
$3.65
$1.64
P/E Ratio
$28.17
$10.08
Revenue Growth
26.34
7.11
52 Week Low
$23.23
$17.30
52 Week High
$50.79
$22.24

Technical Indicators

Market Signals
Indicator
COLL
SPH
Relative Strength Index (RSI) 46.77 62.53
Support Level $43.99 $19.83
Resistance Level $49.31 $20.24
Average True Range (ATR) 1.62 0.50
MACD -0.12 -0.03
Stochastic Oscillator 38.19 73.44

Price Performance

Historical Comparison
COLL
SPH

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About SPH Suburban Propane Partners L.P.

Suburban Propane Partners LP distributes propane, renewable propane, renewable natural gas (RNG), fuel oil, refined fuels, and markets natural gas and electricity in deregulated markets. It produces and invests in low-carbon fuel alternatives. The company installs and services home comfort heating and ventilation equipment and distributes fuel oil, kerosene, diesel, and gasoline to about 25,000 residential and commercial customers mainly in the U.S. northeast. It operates three segments: Propane, Fuel Oil and Refined Fuels, and Natural Gas and Electricity, with the Propane segment generating the majority of revenue. Propane, a by-product of natural gas processing and petroleum refining, is a clean-burning energy source known for transportability and ease of use.

Share on Social Networks: